.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
AstraZeneca
Covington
Dow
Moodys
Boehringer Ingelheim
Cantor Fitzgerald
Colorcon
Argus Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018327

« Back to Dashboard

NDA 018327 describes XENON XE 133, which is a drug marketed by Ge Healthcare, Gen Electric, Lantheus Medcl, and Mallinkrodt Nuclear, and is included in six NDAs. It is available from two suppliers. Additional details are available on the XENON XE 133 profile page.

The generic ingredient in XENON XE 133 is xenon xe-133. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.

Summary for 018327

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 018327

Mechanism of ActionRadiopharmaceutical Activity

Suppliers and Packaging for NDA: 018327

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XENON XE 133 xenon xe-133 GAS;INHALATION 018327 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-097 69945-097-11 1 CAN in 1 CONTAINER (69945-097-11) > 1 BOTTLE in 1 CAN > 2 mL in 1 BOTTLE
XENON XE 133 xenon xe-133 GAS;INHALATION 018327 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-097 69945-097-13 3 CAN in 1 CONTAINER (69945-097-13) > 1 BOTTLE in 1 CAN > 2 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GAS;INHALATIONStrength10mCi/VIAL
Approval Date:Mar 9, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:GAS;INHALATIONStrength20mCi/VIAL
Approval Date:Mar 9, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Citi
Accenture
Deloitte
Covington
Fuji
Farmers Insurance
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot